Neurovascular Embolization Devices Market Top Players- Acandis GmBH, B. Braun, BALT Extrusion, Emboflu, Stryker, Johnson & Johnson.

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Neurovascular Embolization Devices Market- by Product Type (Aneurysm Clips, Liquid Embolic Systems, Flow Diversion Stents, Embolization Coils and Intrasaccular Flow Disruptors), End-Users (Hospitals, Ambulatory Surgical Centers and Specialty Clinics), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."

According to the latest research by InsightAce Analytic, the global Neurovascular Embolization Devices market is valued at USD 1.44 Billion in 2023, and it is expected to reach USD 2.41 Billion by the year 2031, with a CAGR of 6.75% during a forecast period of 2024-2031.

Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1055

Neurovascular embolization devices are utilized in the treatment of abnormal blood vessel formations in the brain, such as brain aneurysms and arteriovenous malformations. These devices work by obstructing or ceasing blood flow to targeted vascular abnormalities. The primary categories of neurovascular embolization devices include intrasaccular flow disruptors, liquid embolic systems, aneurysm clips, flow diversion stents, and embolization coils. Among these, embolization coils are the most commonly used treatment for brain aneurysms, followed by aneurysm clamps and flow diversion stents. Embolization coils are inserted into the aneurysm sac to halt blood flow and induce thrombosis under medical supervision. Post-procedural follow-up imaging is typically necessary, as the potential for residual filling or recurrence of the aneurysm increases the risk of delayed hemorrhage.

The global neurovascular embolization device market is projected to grow, driven by a large target patient population, continuous product innovation, and favorable medical reimbursement policies. This growth is further bolstered by improvements in healthcare infrastructure in emerging economies and an increasing demand for effective neurovascular treatment solutions. Key players in the market are focusing on launching new products and pursuing strategic acquisitions to enhance their market presence. Additionally, ongoing research in neurovascular treatments and a rising preference for minimally invasive neurosurgical techniques are expected to generate new market opportunities.

Despite the positive growth prospects, the market faces challenges such as stringent regulatory requirements and a shortage of skilled neurosurgeons, which could potentially hinder market expansion in the near future.

Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-03

North America is expected to be the leading contributor to the neurovascular embolization devices market throughout the forecast period, fueled by the high concentration of prominent market players and the growing incidence of neurovascular disorders within the region. Additionally, the Asia-Pacific market is projected to witness substantial growth, driven by increased awareness of advanced neurovascular treatments, a large patient demographic, and rising healthcare expenditure. These factors are anticipated to support significant market expansion in the region during the forecast period.

Major market players operating in the Neurovascular Embolization Devices market include
Acandis GmBH, B. Braun, Johnson & Johnson (Cerenovus), KLS Martin, BALT Extrusion, Emboflu, Stryker, Medtronic Plc, Mizuho Medical, Phenox GmBH, Spartan Micro, Peter Lazic GmBH, Terumo Corporation (MicroVention) among others.

Recent collaborations and agreements in the market:
• In February 2021, for the recently acquired radial artery access portfolio from RIST Neurovascular, Inc., Medtronic announced an increase in its limited site release.
• In January 2021, in order to expand their neurovascular business in China, Genesis MedTech Group and Penumbra, Inc. launched a strategic alliance. To establish a neurovascular franchise, the company has opted to complete the purchase of Hua MedTech.
• In December 2020, the intrasaccular aneurysm therapeutic device WEB embolization system from Terumo Corporation was made available in Japan.

Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/1055

Market Segments
Global Neurovascular Embolization Devices Market, by Product Type, 2022-2030 (Value US$ Mn)
• Aneurysm Clips
• Liquid Embolic Systems
• Flow Diversion Stents
• Embolization Coils
• Intrasaccular Flow Disruptors
Global Neurovascular Embolization Devices Market, by End-Users, 2022-2030 (Value US$ Mn)
• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics
Global Neurovascular Embolization Devices Market, by Region, 2022-2030 (Value US$ Mn)
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa
North America Neurovascular Embolization Devices Market, by Country, 2022-2030 (Value US$ Mn)
• U.S.
• Canada
Europe Neurovascular Embolization Devices Market, by Country, 2022-2030 (Value US$ Mn)
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe
Asia Pacific Neurovascular Embolization Devices Market, by Country, 2022-2030 (Value US$ Mn)
• India
• China
• Japan
• South Korea
• Australia & New Zealand
Latin America Neurovascular Embolization Devices Market, by Country, 2022-2030 (Value US$ Mn)
• Brazil
• Mexico
• Rest of Latin America
Middle East & Africa Neurovascular Embolization Devices Market, by Country, 2022-2030 (Value US$ Mn)
• GCC Countries
• South Africa
• Rest of Middle East & Africa

Read Overview Report https://www.insightaceanalytic.com/report/global-neurovascular-embolization-devices-market/1055

Why should buy this report:
• To receive a comprehensive analysis of the prospects for the global Neurovascular Embolization Devices market
• To receive an industry overview and future trends of the Neurovascular Embolization Devices market
• To analyze the Neurovascular Embolization Devices market drivers and challenges
• To get information on the Neurovascular Embolization Devices market value (US$Mn) forecast to 2030
• Significant investments, mergers & acquisitions in the Neurovascular Embolization Devices market industry

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
info@insightaceanalytic.com

This release was published on openPR.